PS
Prasad Sivadas
About Prasad Sivadas
Data last updated:
Prasad Sivadas is a Managing Director at Integron Pharma Private Limited (since 2011). The company operates in Pharma. Integron Pharma Private Limited reported revenue of ₹8.36 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 07 Jan 2011 | 2007 | ₹8.36 Cr (FY 2024) | Active |
Board colleagues of Prasad Sivadas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jasmin Faizal | 01890990 | Integron Pharma Private Limited | Director |
| Jaya Sree Narayanan | 02094701 | Integron Pharma Private Limited | Director |
| Karuvarath Shanoj | 01621857 | Integron Pharma Private Limited | Whole-Time Director |
| Kizhakkapedika Rijo Varghese | 01621765 | Integron Pharma Private Limited | Whole-Time Director |
| Saji Kuzhi Chalil | 03345647 | Integron Pharma Private Limited | Whole-Time Director |
| Thaniyan Salim | 01499223 | Integron Pharma Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prasad Sivadas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prasad Sivadas
Prasad Sivadas currently holds 1 directorship: Integron Pharma Private Limited (Managing Director, since 07 Jan 2011, revenue ₹8.36 Cr (FY 2024)).
Prasad Sivadas was first appointed on 07 Jan 2011 as Managing Director at Integron Pharma Private Limited.
The current boards of Prasad Sivadas's companies include Jasmin Faizal (Integron Pharma Private Limited), Jaya Sree Narayanan (Integron Pharma Private Limited), Karuvarath Shanoj (Integron Pharma Private Limited), Kizhakkapedika Rijo Varghese (Integron Pharma Private Limited), Saji Kuzhi Chalil (Integron Pharma Private Limited), Thaniyan Salim (Integron Pharma Private Limited).